arrow
Back
M

Michael A. Caligiuri

city of hope national medical center

135H-index
864Paper Count
7.0WCitation Count
Published Papers 219
Publication Date
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development
err2026-02-05
err0
errOAAI
errZhenlong Li; Rui Ma; Hejun Tang; Ningyuan Liu; Jianying Zhang; Guido Marcucci; Michael A. Caligiuri; Jianhua Yu
errShare
errSave
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy
err2026-01-08
err0
PREAI
errZahir Shah; Lei Tian; Michael A. Caligiuri; Dan S. Kaufman; Jianhua Yu
errShare
errSave
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy
err2025-08-18
err0
PREAI
errSai Xiao; Songqi Duan; Yaqun Hong; Jianying Zhang; Shoubao Ma; Michael A. Caligiuri; Jianhua Yu
errShare
errSave
YTHDF2: a key RNA reader and antitumor target
err2025-05-20
err0
PREAI
errSai Xiao; Songqi Duan; Michael A. Caligiuri; Shoubao Ma; Jianhua Yu
errShare
errSave
Natural killer cell-based immunotherapy for cancer
err2025-04-01
err0
errOAAI
errMa, Shoubao; Yu, Jianhua; Caligiuri, Michael A.
errShare
errSave
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors
err2025-02-04
err1
errOAAI
errVillalona-Calero, Miguel A.; Tian, Lei; Li, Xiaochen; Palmer, Joycelynne M.; Aceves, Claudia; Meisen, Hans; Cortez, Catherine; Synold, Timothy W.; Egelston, Colt; Vandeusen, Jeffrey; Bruno, Ivone; Zhang, Lei; Romeu-Bonilla, Eliezer; Butt, Omer; Forman, Stephen J.; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer
err2024-06-01
err10
PREAI
errShah, Zahir; Tian, Lei; Li, Zhixin; Jin, Lewei; Zhang, Jianying; Li, Zhenlong; Barr, Tasha; Tang, Hejun; Feng, Mingye; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion
err2024-05-31
err4
errOAAI
errXiao, Sai; Ma, Shoubao; Sun, Baofa; Pu, Wenchen; Duan, Songqi; Han, Jingjing; Hong, Yaqun; Zhang, Jianying; Peng, Yong; He, Chuan; Yi, Ping; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
YTHDF2 promotes tumor immune evasion by inhibiting CD8+T cell-mediated anti-tumor immunity
err2024-05-01
err0
PREAI
errMa, Shoubao; Xiao, Sai; Caligiuri, Michael; Yu, Jianhua
errShare
errSave
Specific activation of the Epstein-Barr Virus BGLF4 locus via lowered DNA methylation in EBV-associated CNS lymphoproliferative disease
err2024-04-05
err0
PREAI
errWeigel, Christoph; Klimaszewski, Haley L.; Addissie, Selamawit; Schlotter, Sarah; Tounkara, Fode; Dugan, James P.; Haverkos, Bradley M.; Villagomez, Lynda; Lustberg, Mark; Porcu, Pierluigi; Voorhees, Timothy; Caligiuri, Michael A.; Bumgardner, Ginny; Oakes, Christopher C.; Baiocchi, Robert
errShare
errSave
Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia
err2023-10-13
err11
errOAAI
errMansour, Anthony G.; Teng, Kun-Yu; Li, Zhiyao; Zhu, Zheng; Chen, Hanyu; Tian, Lei; Ali, Aliya; Zhang, Jianying; Lu, Ting; Ma, Shoubao; Lin, Chih-Min; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
Harnessing Natural Killer Cells for Lung Cancer Therapy
err2023-08-02
err5
PREAI
errMa, Shoubao; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma (vol 6, e141683, 2021)
err2023-07-24
err2
errOAAI
errLewinsky, Hadas; Gunes, Emine G.; David, Keren; Radomir, Lihi; Kramer, Matthias P.; Pellegrino, Bianca; Perpinial, Michal; Chen, Jing; He, Ting-fang; Mansour, Anthony G.; Teng, Kun-Yu; Bhattacharya, Supriyo; Caserta, Enrico; Troadec, Estelle; Lee, Peter; Feng, Mingye; Keats, Jonathan; Krishnan, Amrita; Rosenzweig, Michael; Yu, Jianhua; Caligiuri, Michael A.; Cohen, Yosef; Shevetz, Olga; Becker-Herman, Shirly; Pichiorri, Flavia; Rosen, Steven; Shachar, Idit
errShare
errSave
Viral- and tumor-reactive natural killer cells
err2023-05-01
err6
errOAAI
errYu, Jianhua; Caligiuri, Michael A.
errShare
errSave
Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection
err2023-04-06
err6
errOAAI
errDong, Wenjuan; Wang, Jing; Tian, Lei; Zhang, Jianying; Settles, Erik W.; Qin, Chao; Steinken-Kollath, Daniel R.; Itogawa, Ashley N.; Celona, Kimberly R.; Yi, Jinhee; Bryant, Mitchell; Mead, Heather; Jaramillo, Sierra A.; Lu, Hongjia; Li, Aimin; Zumwalt, Ross E.; Dadwal, Sanjeet; Feng, Pinghui; Yuan, Weiming; Whelan, Sean P. J.; Keim, Paul S.; Barker, Bridget Marie; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells
err2023-03-31
err9
errOAAI
errMa, Shoubao; Han, Jingjing; Li, Zhenlong; Xiao, Sai; Zhang, Jianying; Yan, Jiazhuo; Tang, Tingting; Barr, Tasha; Kraft, Andrew S.; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave
PKR induces TGF-β and limits oncolytic immune therapy
err2023-02-16
err3
errOAAI
errHong, Bangxing; Sahu, Upasana; Mullarkey, Matthew P.; Hong, Evan; Pei, Guangsheng; Yan, Yuanqing; Otani, Yoshihiro; Banasavadi-Siddegowda, Yeshavanth; Fan, Huihui; Zhao, Zhongming; Yu, Jianhua; Caligiuri, Michael A.; Kaur, Balveen
errShare
errSave
The emerging field of oncolytic virus-based cancer immunotherapy
err2023-02-01
err109
errOAAI
errMa, Rui; Li, Zhenlong; Chiocca, E. Antonio; Caligiuri, Michael A.; Yu, Jianhua
errShare
errSave